Eterna Therapeutics Inc. (NASDAQ: ERNA)
$0.2549
+0.0095 ( -0.04% ) 97.3K
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Market Data
Open
$0.2549
Previous close
$0.2454
Volume
97.3K
Market cap
$12.62M
Day range
$0.2430 - $0.2550
52 week range
$0.2212 - $2.6250
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 80 | Nov 12, 2024 |
4 | Insider transactions | 1 | Nov 05, 2024 |
8-k | 8K-related | 16 | Oct 29, 2024 |
ars | Annual reports | 1 | Oct 16, 2024 |
def | Proxies and info statements | 6 | Oct 07, 2024 |
8-k | 8K-related | 13 | Sep 27, 2024 |
pre | Proxies and info statements | 6 | Sep 27, 2024 |
8-k | 8K-related | 22 | Sep 25, 2024 |
8-k | 8K-related | 13 | Sep 23, 2024 |
8-k | 8K-related | 13 | Aug 19, 2024 |